论文信息 - Superior Efficacy of Dolutegravir (DTG) Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared with lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment — 48-week Data from the DAWNING Study - 字舞流文

Superior Efficacy of Dolutegravir (DTG) Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared with lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment — 48-week Data from the DAWNING Study

J. Gatell | Kimberly Smith | M. Aboud | R. Kaplan | M. Losso | C. Brites | P. Chetchotisakd | Fujie Zhang | J. Lombaard | M. Underwood | C. Steinhart | J. Hidalgo | Dannae Brown | Elmira Mamedova | J. Sievers | J. Hopking | M. Nascimento | M. Gartland | Jörg Sievers